Veracyte acquires C2i Genomics for $95m to boost cancer diagnostics range
Veracyte also expects to have increased its revenue in 2023 by 21%, totalling between $358m and $359m. Image credit: Shutterstock/Michael Vi. US-based Veracyte has agreed to acquire minimal residual disease (MRD) test developer C2i genomics in a deal worth up to $95m, strengthening its range of cancer diagnostic products. Veracyte will pay compatriot C2i $70m […]
Clarius’ new Bladder AI tool receives FDA 510(k) clearance
The new Clarius Bladder AI ultrasound scanner can be used for monitoring urinary retention. Credit: PRNewswire/ Clarius Mobile Health. Clarius Mobile Health has received the US Food and Drug Administration (FDA) 510(k) clearance for its Clarius Bladder AI [artificial intelligence] non-invasive tool designed to automatically measure bladder volume. The tool serves as a versatile and […]
Neurolief’s neuromodulation device approved as migraine therapy in Japan
Neurolief’s Relivion has two versions – RelivionMG for the treatment of migraine and RelivionDP for major depressive disorder (MDD). Image Credit: Neurolief. US-based Neurolief’s neuromodulation device, Relivion has been approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) for at-home use in the acute treatment of migraine. Relivion is a non-invasive multi-channel brain […]
GE Healthcare acquires MIM Software for undisclosed amount
The deal comes as GE HealthCare seeks to acquire MIM Software’s suite of diagnostic imaging technologies. Credit: Shutterstock / JHVEPhoto GE HealthCare has entered into an agreement to acquire medical imaging firm MIM Software. GE HealthCare will take over MIM Software’s suite of diagnostic imaging technologies complete with artificial intelligence (AI) powered solutions to expand […]
Spinal cord charity launches trial to restore bowel functions
The ImPRESS project at the London Spinal Injuries Centre (LSIC) will look to examine whether spinal cord stimulation technology can be used to restore bowel functions. Credit: Shutterstock / Olena Yakobchuk UK-based charity Spinal Research is launching a trial aimed at restoring bowel functionality in patients living with a spinal injury, backed by a £300,000 […]
3D-printing technology to produce functional human organs
This breakthrough includes the successful 3D printing of hearts, kidneys, livers and other vital organs. Credit: everytime via Shutterstock. As we enter the new year, notable advancements in the field of medicine are unfolding. In 2024, a significant breakthrough is taking place as 3D-printing technology progresses to create fully functional human organs. This pivotal achievement […]
NVIDIA partners with Amgen to build generative AI models for drug discovery
GlobalData forecasts that the artificial intelligence (AI) market will be worth $908.7bn in 2030. Credit: metamorworks via Getty Images. US-based technology company NVIDIA has entered a collaboration with Amgen to build artificial intelligence (AI) models. Amgen will deploy the AI model-building platform, named Freyja, at the deCODE genetics headquarters in Reykjavik, Iceland. The system aims […]
US FDA approves ZetrOZ’s sam 2.0 unit for additional uses
The device can now be used for treating knee osteoarthritis, upper back myofascial pain, among others. Credit: YURII MASLAK/shutterstock.com. The US Food and Drug Administration (FDA) has granted clearance to ZetrOZ Systems’ sustained acoustic medicine device, the sam 2.0 wearable ultrasound unit, broadening its use for various medical conditions. ZetrOZ’s sam is a low-intensity, long-duration, […]
Medline introduces OptiView transparent dressing
The OptiView transparent dressing features an innovative clear design to allow caregivers to quickly and easily inspect skin. Credit: PRNewswire/Medline. Medline has launched OptiView transparent dressing with HydroCore Technology to allow easy assessment of at-risk skin and monitoring skin breakdown. The design of the dressing allows caregivers to inspect and monitor the skin quickly and […]
Zedsen to test electrical sensing device in UK cancer trial
The DiCET clinical research study will enrol 90 participants at London’s Charing Cross Hospital. Image credit: Shutterstock/briddy. Biosensor company Zedzen has partnered with the Imperial College Healthcare NHS Trust to conduct a clinical study investigating its non-invasive sensing device. The DiCET clinical research study will enrol 90 participants at London’s Charing Cross Hospital, commencing in […]